Destiny Pharma PLC
LSE:DEST
Income Statement
Earnings Waterfall
Destiny Pharma PLC
Income Statement
Destiny Pharma PLC
| Dec-2017 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||
| Operating Expenses |
(3)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(6)
|
(7)
|
(8)
|
(7)
|
(7)
|
|
| Selling, General & Administrative |
(2)
|
(3)
|
(6)
|
(2)
|
(6)
|
(2)
|
(7)
|
(3)
|
(7)
|
(3)
|
(8)
|
(8)
|
|
| Research & Development |
(1)
|
(3)
|
0
|
(4)
|
0
|
(4)
|
0
|
(4)
|
0
|
(5)
|
0
|
0
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Operating Income |
(3)
N/A
|
(6)
-93%
|
(6)
+4%
|
(6)
+7%
|
(6)
-10%
|
(7)
-8%
|
(7)
-1%
|
(6)
+4%
|
(7)
-13%
|
(8)
-9%
|
(7)
+7%
|
(7)
+7%
|
|
| Pre-Tax Income | |||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(3)
N/A
|
(6)
-87%
|
(6)
+3%
|
(6)
+6%
|
(6)
-9%
|
(6)
-7%
|
(7)
0%
|
(6)
+4%
|
(7)
-13%
|
(8)
-9%
|
(7)
+9%
|
(6)
+9%
|
|
| Net Income | |||||||||||||
| Tax Provision |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Income from Continuing Operations |
(3)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(7)
|
(6)
|
(6)
|
|
| Net Income (Common) |
(3)
N/A
|
(5)
-74%
|
(5)
+4%
|
(5)
+6%
|
(5)
-7%
|
(5)
-7%
|
(5)
-1%
|
(5)
+2%
|
(6)
-13%
|
(7)
-8%
|
(6)
+8%
|
(6)
+5%
|
|
| EPS (Diluted) |
-0.08
N/A
|
-0.12
-50%
|
-0.11
+8%
|
-0.11
N/A
|
-0.11
N/A
|
-0.12
-9%
|
-0.11
+8%
|
-0.09
+18%
|
-0.1
-11%
|
-0.09
+10%
|
-0.08
+11%
|
-0.06
+25%
|
|